Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2015 1
2016 1
2018 4
2019 3
2020 9
2021 5
2022 5
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Cancer Stem Cells in Soft-Tissue Sarcomas.
Martínez-Delgado P, Lacerenza S, Obrador-Hevia A, Lopez-Alvarez M, Mondaza-Hernandez JL, Blanco-Alcaina E, Sanchez-Bustos P, Hindi N, Moura DS, Martin-Broto J. Martínez-Delgado P, et al. Among authors: moura ds. Cells. 2020 Jun 10;9(6):1449. doi: 10.3390/cells9061449. Cells. 2020. PMID: 32532153 Free PMC article. Review.
New drugs in gastrointestinal stromal tumors.
Martin-Broto J, Moura DS. Martin-Broto J, et al. Among authors: moura ds. Curr Opin Oncol. 2020 Jul;32(4):314-320. doi: 10.1097/CCO.0000000000000642. Curr Opin Oncol. 2020. PMID: 32541319 Review.
Facts and Hopes in Immunotherapy of Soft-Tissue Sarcomas.
Martín-Broto J, Moura DS, Van Tine BA. Martín-Broto J, et al. Among authors: moura ds. Clin Cancer Res. 2020 Nov 15;26(22):5801-5808. doi: 10.1158/1078-0432.CCR-19-3335. Epub 2020 Jun 29. Clin Cancer Res. 2020. PMID: 32601077 Free PMC article. Review.
Efficacy of Eribulin Plus Gemcitabine Combination in L-Sarcomas.
López-Álvarez M, González-Aguilera C, Moura DS, Sánchez-Bustos P, Mondaza-Hernández JL, Martín-Ruiz M, Renshaw M, Ramos R, Castilla C, Blanco-Alcaina E, Hindi N, Martín-Broto J. López-Álvarez M, et al. Among authors: moura ds. Int J Mol Sci. 2022 Dec 30;24(1):680. doi: 10.3390/ijms24010680. Int J Mol Sci. 2022. PMID: 36614121 Free PMC article.
ISG15 as a prognostic biomarker in solitary fibrous tumour.
Mondaza-Hernandez JL, Moura DS, Lopez-Alvarez M, Sanchez-Bustos P, Blanco-Alcaina E, Castilla-Ramirez C, Collini P, Merino-Garcia J, Zamora J, Carrillo-Garcia J, Maestro R, Hindi N, Garcia-Foncillas J, Martin-Broto J. Mondaza-Hernandez JL, et al. Among authors: moura ds. Cell Mol Life Sci. 2022 Jul 21;79(8):434. doi: 10.1007/s00018-022-04454-4. Cell Mol Life Sci. 2022. PMID: 35864381 Free PMC article.
A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors.
Martin-Broto J, Redondo A, Moura DS, Valverde C, Morales JM, Lopez-Pousa A, Martinez-Trufero J, Gutierrez A, Díaz-Beveridge R, Luna P, Martinez-Marin V, Marcilla D, Arribas I, Ledesma P, Lopez-Martin JA, Di Lernia D, Zamora J, Hindi N. Martin-Broto J, et al. Among authors: moura ds. Nat Commun. 2022 Oct 21;13(1):6278. doi: 10.1038/s41467-022-33975-6. Nat Commun. 2022. PMID: 36271011 Free PMC article. Clinical Trial.
Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial.
Martin-Broto J, Cruz J, Penel N, Le Cesne A, Hindi N, Luna P, Moura DS, Bernabeu D, de Alava E, Lopez-Guerrero JA, Dopazo J, Peña-Chilet M, Gutierrez A, Collini P, Karanian M, Redondo A, Lopez-Pousa A, Grignani G, Diaz-Martin J, Marcilla D, Fernandez-Serra A, Gonzalez-Aguilera C, Casali PG, Blay JY, Stacchiotti S. Martin-Broto J, et al. Among authors: moura ds. Lancet Oncol. 2020 Mar;21(3):456-466. doi: 10.1016/S1470-2045(19)30826-5. Epub 2020 Feb 14. Lancet Oncol. 2020. PMID: 32066540 Clinical Trial.
29 results